Shock therapy for leg pain? tiny trial tests TENS plus coaching to get people moving

NCT ID NCT06114732

Recruiting now Symptom relief Sponsor: Glasgow Caledonian University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a TENS pain-relief device, combined with video coaching sessions from a physiotherapist, can help people with leg pain from peripheral artery disease (PAD) become more active. Forty-eight participants will either get the TENS device plus coaching or usual care. The goal is to see if this approach is practical and acceptable, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcutaneous Electrical Nerve Stimulation (TENS) device
What this could lead to: If it works, this approach could offer a practical, home-based way to reduce leg pain and improve walking ability for people with peripheral artery disease.
What could go wrong: This is a very small feasibility trial (48 people) testing whether the methods work, not whether the treatment is effective. The TENS device may not reduce pain enough to make a real difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERMITTENT CLAUDICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia intermittent vascular claudication peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERMITTENT CLAUDICATION PERIPHERAL ARTERY DISEASE

Contacts and locations

Locations

NHS Lanarkshire
RECRUITING

Glasgow, Lanarkshire, G75 8RG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.